WB
The startup develops antibody drugs targeting refractory tumors in adolescents and young adults, focusing on rare cancers with significant unmet medical needs. By providing effective treatment options, the company aims to improve patient access to essential therapies for these challenging conditions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops antibody drugs targeting refractory tumors in adolescents and young adults, focusing on rare cancers with significant unmet medical needs. By providing effective treatment options, the company aims to improve patient access to essential therapies for these challenging conditions.